Gastrointestinal Cancer News

The FDA office that reviews applications for cancer therapies has been renamed and reorganized.

Chemotherapy combined with hepatic arterial infusion of floxuridine or with selective internal radiotherapy induced antitumor activity among patients with unresectable intrahepatic cholangiocarcinoma, according to results of separate phase 2 studies published in JAMA Oncology.

The ACP has issued a new evidence-based guidance statement on screening for colorectal cancer screening in asymptomatic adults with average risk.

A phase 3 trial designed to assess an investigational drug for first-line treatment of metastatic pancreatic cancer failed to meet its primary endpoint of OS, according to the agent’s manufacturer.

SAN ANTONIO — In this exclusive video from the American College of Gastroenterology Annual Meeting, Aasma Shaukat, MD, MPH, FACG, professor of medicine at University of Minnesota and GI Section Chief at the Minneapolis VA Medical Center, discusses a major debate in colorectal cancer screening and surveillance.

The National Academy of Medicine announced the election of 90 regular members and 10 international members.

Anti-EGFR therapy showed promising efficacy for certain patients with non-V600 BRAF-mutated metastatic colorectal cancer, according to results of a multicenter, pooled analysis published in Clinical Cancer Research.

William G. Cance, MD, has begun his new role as American Cancer Society’s chief medical and scientific officer.

Halle Moore, MD, has been appointed director of breast medical oncology at Cleveland Clinic.

African American and Hispanic patients who underwent pancreatectomy for pancreatic cancer appeared less likely than their white counterparts to utilize hospice services more than 3 days before death, according to results of a retrospective study scheduled for presentation at Supportive Care in Oncology Symposium.